Literature DB >> 10362807

Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia.

R F Willenbucher1, D E Aust, C G Chang, S J Zelman, L D Ferrell, D H Moore, F M Waldman.   

Abstract

Ulcerative colitis (UC) is a chronic inflammatory disease of the colon associated with a high risk of colorectal cancer. This increased cancer risk is thought to result from the cellular damage induced by the inflammatory field. The aim of this study was to determine the pattern and time course of genomic instability occurring in UC-related neoplasia. Sites of cancer, dysplasia, and nondysplasia from 14 UC colectomy cases containing cancer were analyzed for chromosomal alterations by comparative genomic hybridization (CGH) and for microsatellite instability using a series of 10 microsatellite markers. Clonal chromosomal alterations were present in 85% of cancer sites, 86% of dysplasia sites, and 36% of nondysplasia sites. Losses of chromosome 18 or 18q and chromosome 5 or 5q were common in cancer and dysplasia and were occasionally detected in nondysplasia. High-level microsatellite instability was detected in the cancer and dysplasia of two cases. Samples that demonstrated high-level microsatellite instability were unlikely to have chromosomal alterations demonstrable by CGH. These studies suggest that the predominant type of genomic instability in UC-related neoplasia is associated with chromosomal alterations and that this type of genomic instability frequently occurs before the development of histologically defined dysplasia.

Entities:  

Mesh:

Year:  1999        PMID: 10362807      PMCID: PMC1866629          DOI: 10.1016/S0002-9440(10)65438-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma.

Authors:  G C Burmer; D S Levine; B G Kulander; R C Haggitt; C E Rubin; P S Rabinovitch
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

4.  DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia.

Authors:  R Löfberg; O Broström; P Karlén; A Ost; B Tribukait
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

5.  Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis.

Authors:  G C Burmer; D A Crispin; V R Kolli; R C Haggitt; B G Kulander; C E Rubin; P S Rabinovitch
Journal:  Cancer Commun       Date:  1991-06

6.  The DCC gene: structural analysis and mutations in colorectal carcinomas.

Authors:  K R Cho; J D Oliner; J W Simons; L Hedrick; E R Fearon; A C Preisinger; P Hedge; G A Silverman; B Vogelstein
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

7.  Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele.

Authors:  G C Burmer; P S Rabinovitch; R C Haggitt; D A Crispin; T A Brentnall; V R Kolli; A C Stevens; C E Rubin
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

8.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

9.  Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.

Authors:  B D Greenwald; N Harpaz; J Yin; Y Huang; Y Tong; V L Brown; T McDaniel; C Newkirk; J H Resau; S J Meltzer
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

10.  Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected].

Authors:  S E Kern; E R Fearon; K W Tersmette; J P Enterline; M Leppert; Y Nakamura; R White; B Vogelstein; S R Hamilton
Journal:  JAMA       Date:  1989-06-02       Impact factor: 56.272

View more
  43 in total

1.  Genetic instability and the mutator phenotype. Studies in ulcerative colitis.

Authors:  K R Loeb; L A Loeb
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 3.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 4.  Tumbling down a different pathway to genetic instability.

Authors:  Haiwei H Guo; Lawrence A Loeb
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  The biology of incipient, pre-invasive or intraepithelial neoplasia.

Authors:  William E Grizzle; Sudhir Srivastava; Upender Manne
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 6.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

Review 7.  Role of SMAD proteins in colitis-associated cancer: from known to the unknown.

Authors:  P Chandrasinghe; B Cereser; M Moorghen; I Al Bakir; N Tabassum; A Hart; J Stebbing; J Warusavitarne
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

8.  Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.

Authors:  Joel Pekow; Urszula Dougherty; Yong Huang; Edward Gometz; Jeff Nathanson; Greg Cohen; Shawn Levy; Masha Kocherginsky; Nanda Venu; Maria Westerhoff; John Hart; Amy E Noffsinger; Stephen B Hanauer; Roger D Hurst; Alessandro Fichera; Loren J Joseph; Qiang Liu; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

9.  Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer.

Authors:  Sabine Tejpar; Robert D Odze
Journal:  Gastrointest Cancer Res       Date:  2009-09

10.  Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis.

Authors:  Marco Gerling; Kari Nousiainen; Sampsa Hautaniemi; Stefan Krüger; Britta Fritzsche; Nils Homann; Hans-Peter Bruch; Gert Auer; Uwe J Roblick; Thomas Ried; Jens K Habermann
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.